Company overview
ZEISS provides comprehensive microscopy solutions for pharmaceutical R&D and biopharma, including light, confocal, electron, and X-ray microscopes with AI-powered image analysis software. Their offerings span high-resolution imaging, live-cell imaging, 3D volumetric analysis, and high-content screening, supported by both capital equipment sales and flexible Microscopy as a Service options. ZEISS integrates advanced automation, machine learning segmentation, and expert workflows to accelerate drug discovery, tissue analysis, and quality assurance. The company serves life sciences research, materials characterization, and clinical diagnostics with proven infrastructure and customizable solutions.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with ZEISS include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.zeiss.com/microscopy/en/home.html?vaURL=www.zeiss.com/microscopy
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- pharmaceutical microscopy, confocal imaging, high-content screening, 3d volumetric imaging, ai image analysis
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What microscopy modalities does ZEISS offer for pharmaceutical research?
- ZEISS offers light microscopes, confocal systems (LSM Airyscan), electron microscopes, and X-ray microscopes. Their platforms support high-resolution imaging, live-cell imaging, super-resolution imaging, 3D volumetric imaging, and high-plex fluorescence imaging with spectral unmixing capabilities for multiplexed marker detection.
- Does ZEISS provide service-based alternatives to capital equipment purchases?
- Yes. ZEISS Microscopy as a Service provides access to cutting-edge imaging technologies, proven workflows, and expert support without requiring capital equipment investment. Services include high-resolution imaging, 3D analysis, tissue multiplexing, high-content screening, and slide scanning tailored to life sciences and biopharma needs.
- What AI and automation capabilities does ZEISS integrate into their systems?
- ZEISS incorporates AI-powered image analysis through ZEN and arivis software, featuring automated segmentation, cell tracking, and quantitative measurements. Their ZEN Guided Acquisition Module integrates microscopy automation with AI-powered analysis, and their Xradia 3D X-ray platform uses deep learning-based reconstruction to accelerate data acquisition by over 10X while maintaining image quality.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
